RSS Feed Print
A doctor's story of a promising drug
Posted: Monday, September 26, 2016 7:30 AM
Joined: 2/26/2016
Posts: 276

Read this article above about a medical doctor who discovered a drug combination to greatly increase heart attack survival, and no drug company is interested in making it.

Dr. Harry Selker at Tufts Medical Center in Boston designed a study in which persons appearing to have heart attacks were injected by paramedics with a combination of glucose, insulin and potassium (GIK).The results showed that people given GIK were less likely to suffer cardiac arrest and death. The drug also reduced the amount of heart damage for survivors by 80 percent, which could mean the difference between recovery and heart failure. These incrediable results were published in 2012. Since then no drug company has shown an interest in sponsoring clinical trials and marketing the drug combination because it is made up of inexpensive drugs that can't be patented. In other words they can't make a lot of money off it. 

What if this was a drug that could get a patent or could get special approval as a medical device? It would become another Epi-pen money maker for the medical emergency industry. Instead of selling for a few dollars, they could sell it for a thousand plus dollars a pop. They could make the point that tens of thousands of more people will survive who would have died and perhaps hundreds of thousands of others will live with less heart damage. The company could hire thousands of lobbiests to decend on state capitals and the Congress (just like Epi-pen) and push laws that every ambulance and emergency room is well stocked with their injectors. Politicians could get more money, and doctors and patient advocates could also get lots of money from the company for their support. The company officials and stockholders would make lots of money, and everybody would be happy, except maybe people who pay for increases in medical insurance or pay out of pocket or can't pay and don't get the drug. All this for some inexpensive drugs that only cost a few dollars to make.

Don't you think that our government is failing us when it doesn't put promising drugs that don't have Big Pharma's backing into clinical trials. The government should be paying for these clinic trials and doing them without delay. And if no company wants to market them because they can't make enough money, then maybe the government should contract with companies to make the drugs and distribute them itself, the way they do vaccines. In the end, the government saves money when people have better health outcomes, because there is less money being paid out in medicare, medicaid and disability payments. And people benefit by having longer and healthier lives.


Posted: Wednesday, September 28, 2016 4:29 AM
Joined: 4/6/2014
Posts: 692

I have always felt that drug companies what to treat and not cure the problem. I have been a diabetic for 50 years and have heard about promising cures but nothing has come to market.